BioSpace News Archive

Business

Medtronic Board Appoints Kevin Lofton as a New Director

Medtronic plc announced that its Board of Directors appointed Kevin Lofton to the Board as an independent director, effective September 15, 2020.

August 24, 2020
·
2 min read
Policy

BrainsWay Receives FDA Clearance for Smoking Addiction in Adults

This is the Company’s third FDA-cleared indication for its Deep TMS System, and is the first FDA clearance in the addiction space for any TMS device

August 24, 2020
·
7 min read
Deals

Algernon Announces Research Analyst Coverage by Mackie Research with an $0.80/share Target Price

Algernon Pharmaceuticals Inc. a clinical stage pharmaceutical development company, is pleased to announce that research on the Company has been initiated by André Uddin, Managing Director Healthcare at Mackie Research Capital Corporation with a speculative buy recommendation and a target price of $0.80/share.

August 24, 2020
·
3 min read
BioMidwest

Centene Subsidiary Selected to Continue Serving Hoosier Care Connect Members

Centene Corporation announced its Indiana subsidiary, Managed Health Services, has been selected by the Indiana Department of Administration to continue serving Hoosier Care Connect members with Medicaid managed care and care coordination services.

August 24, 2020
·
9 min read
Business

MITRE and Nuance Use AI to Help Oncologists Quickly and Accurately Collect Data to Improve Cancer Research and Treatment

Nuance Dragon Medical One cloud-based speech recognition solution reduces burden to clinicians and helps improve quality of available cancer data

August 24, 2020
·
5 min read
Business

Harbour BioMed Signs Strategic Collaboration Agreement with Vir Biotechnology to Develop Novel Therapies for Immuno-Oncology and Infectious Diseases

Harbour BioMed, a global clinical-stage biopharmaceutical company announced that it has entered into a strategic collaboration with Vir Biotechnology, a clinical-stage immunology company, to discover, develop and commercialize potential novel therapeutic molecules in the fields of Immuno-Oncology and infectious diseases.

August 24, 2020
·
2 min read
Deals

Ortho Regenerative Technologies Closes Non-Brokered $2.5 Million Private Placement

Ortho Regenerative Technologies Inc., an emerging orthobiologics company focused on the development of novel soft tissue repair regenerative technologies, announced the closing of a non-brokered $2.5 million private placement of units.

August 24, 2020
·
5 min read
Business

Leap Therapeutics Expands Leadership Team with Addition of Two Industry Veterans

Jason Baum, Ph.D., Joins as Vice President, Head of Translational Medicine Christine Granfield Named Vice President, Head of Regulatory Affairs and Quality

August 24, 2020
·
5 min read
Drug Development

Akcea and Ionis to Present Phase 2 Clinical Data of Vupanorsen (AKCEA-ANGPTL3-L (Rx) ) at ESC Congress 2020

Late-breaking presentation to focus on efficacy and safety data of vupanorsen in patients with hypertriglyceridemia, type 2 diabetes and non-alcoholic fatty liver disease

August 24, 2020
·
6 min read
Deals

Yumanity Therapeutics and Proteostasis Therapeutics Announce Merger Agreement

Focus on Yumanity’s lead clinical program in Parkinson’s disease and transformative pipeline of disease-modifying treatments for neurogenerative disorders

August 24, 2020
·
14 min read